首页|体外循环手术停机困难转静脉-动脉体外膜肺氧合的建立配合与转运管理

体外循环手术停机困难转静脉-动脉体外膜肺氧合的建立配合与转运管理

扫码查看
目的 探讨体外循环(CPB)手术停机困难转静脉-动脉体外膜肺氧合(VA-ECMO)的建立方法、配合要点及术后安全转运管理策略.方法 采用观察性研究方法,选择2020年1月至2022年10月皖南医学院第一附属医院(弋矶山医院)重症医学科收治的无法脱离CPB而应用VA-ECMO辅助的CPB手术患者.记录患者的临床资料,包括患者的基本资料、VA-ECMO建立及转运过程资料、VA-ECMO上机前后临床指标、VA-ECMO运行资料及临床结局,从体外膜肺氧合(ECMO)建立、转运过程、团队配合、转运过程中不良事件等方面进行经验总结,并比较ECMO上机前后临床指标;根据是否成功撤离ECMO分为撤机成功组与失败组,比较两组患者临床资料.结果 最终共纳入18例CPB转VA-ECMO辅助患者,其中男性10例,女性8例;年龄(56.7±12.3)岁;术前左室射血分数(LVEF)0.46±0.10;转VA-ECMO辅助的主要原因包括右心室收缩乏力6例,全心收缩乏力5例,左心室收缩乏力4例,肺动脉高压2例,顽固性心室纤颤1例;18例CPB转VA-ECMO辅助患者成功撤机10例,失败8例;ICU内存活8例,死亡5例,放弃治疗出院5例;CPB转VA-ECMO成功建立时间(24.6±7.4)min,初始血流量(3.3±0.4)L/min,转运时间(8.4±1.5)min,ECMO 辅助时间(82.0±69.3)h;ECMO建立及转运过程中有9例患者发生不同分级不良事件.与CPB转VA-ECMO上机前相比,患者上机4 h血乳酸(Lac)、pH值、平均动脉压(MAP)、中心静脉血氧饱和度(ScvO2)均得到显著改善[Lac(mmol/L):10.5±7.0比15.2±6.8,pH 值:7.38±0.92 比 7.26±0.87,MAP(mmHg,1 mmHg≈0.133 kPa):74.9±13.7 比 58.4±17.0,ScvO2:0.678±0.065比0.611±0.061,均P<0.01],且血管活性药-强心药评分(VIS)亦显著降低(分:39.8±29.8比68.9±64.4,P<0.01).与撤机成功组相比,撤机失败组患者上机前Lac更高(mmol/L:18.8±7.8比12.3±4.3,P<0.05),CPB 时间更长[min:238.0(208.8,351.2)比 200.0(185.8,217.0),P<0.05],ECMO 辅助时间更短[h:19.5(11.0,58.8)比 94.5(65.8,179.8),P<0.01];两组患者上机前 pH 值、ScvO2、MAP、VIS 评分及 ECMO 初始血流量和建立时间差异均无统计学意义.结论 VA-ECMO是CPB手术患者术中无法脱机的有效循环辅助手段,CPB"桥"对ECMO辅助的建立及转运依托于多学科团队协作(MDT);ECMO撤机成功率与Lac、CPB时间有关,若无法顺利脱离CPB,则应及早启动VA-ECMO.
Establishment and transfer management of veno-arterial extracorporeal membrane oxygenation in patients with difficult downtime during cardiopulmonary bypass surgery
Objective To investigate the establishment method,coordination points and safe transport management strategy of vena-arterial extracorporeal membrane oxygenation(VA-ECMO)in patients with downtime difficulties during cardiopulmonary bypass(CPB).Methods A observation study was conducted.The patients admitted to the department of critical care medicine of the First Affiliated Hospital of Wannan Medical College(Yijishan Hospital)from January 2020 to October 2022 were enrolled.These patients could not be separated from CPB and received VA-ECMO-assisted CPB surgery.The clinical data of the patients were recorded,including the basic information of the patients,the data of VA-ECMO establishment and transport process,the clinical indicators before and after VA-ECMO installation,the operation data of VA-ECMO and clinical outcomes.The experience was summarized from the aspects of extracorporeal membrane oxygenation(ECMO)establishment,transport process,team cooperation,and adverse events during transport.The clinical indicators before and after ECMO operation were compared.According to whether ECMO was successfully weaned,the patients were divided into a successful weaning group and a failure weaning group,and the clinical data between the two groups were compared.Results Eighteen patients who underwent VA-ECMO-assisted CPB were enrolled,including 10 males and 8 females.The average age was(56.7±12.3)years old.Preoperative left ventricular ejection fraction(LVEF)was 0.46±0.10,and the main reasons for switching to VA-ECMO assistance included right ventricular systolic weakness in 6 cases,total cardiac systolic weakness in 5 cases,left ventricular systolic weakness in 4 cases,high pulmonary arterial pressure in 2 cases,and intractable ventricular fibrillation in 1 case.Among the 18 patients transferred from CPB to VA-ECMO,10 cases were successfully weaned and 8 cases failed.In ICU,8 cases survived,5 cases died,and 5 cases gave up treatment and discharged.The average time for successful CPB to VA-ECMO establishment was(24.6±7.4)minutes,initial blood flow was(3.3±0.4)L/min,and transit time was(8.4±1.5)minutes.ECMO-assisted duration averaged(82.0±69.3)hours.Adverse events occurred in 9 patients during ECMO establishment and transfer.Post-ECMO onboarding for 4 hours,significant improvements were noted in blood lactic acid(Lac),pH value,mean arterial pressure(MAP),central venous oxygen saturation(ScvO2)as compared with pre-ECMO onboarding[Lac(mmol/L):10.5±7.0 vs.15.2±6.8,pH value:7.38±0.92 vs.7.26±0.87,MAP(mmHg,1 mmHg≈ 0.133 kPa):74.9±13.7 vs.58.4±17.0,ScvO2:0.678±0.065 vs.0.611±0.061,all P<0.01],and vasoactive-inotropic score(VIS)was also decreased(39.8±29.8 vs.68.9±64.4,P<0.01).Compared with successful weaning group,the patients in the failed weaning group exhibited higher pre-machine Lac(mmol/L:18.8±7.8 vs.12.3±4.3,P<0.05),longer CPB time[minutes:238.0(208.8,351.2)vs.200.0(185.8,217.0),P<0.05],and shorter ECMO-assisted time[hours:19.5(11.0,58.8)vs.94.5(65.8,179.8),P<0.01].However,there was no statistically significant difference in pre-machine pH value,ScvO2,MAP,VIS score,and initial blood flow and establishment time of ECMO between the two groups.Conclusions VA-ECMO is an effective circulatory aid for CPB surgery that cannot be weaned after CPB.The establishment and transfer of CPB"bridge"to ECMO aid depends on multi-disciplinary treatment(MDT)cooperation.The success rate of ECMO weaning is related to the Lac and CPB duration.If it is not possible to detach from the CPB successfully,VA-ECMO should be initiated as early as possible.

Cardiac surgeryExtracorporeal membrane oxygenationCardiopulmonary bypassTransport

方可、笪欢欢、孙瑞祥、汪君、王教婷、江海娇、王涛、徐前程

展开 >

皖南医学院第一附属医院(弋矶山医院)重症医学科,安徽省危重症呼吸疾病临床医学研究中心,安徽芜湖 241000

皖南医学院第一附属医院(弋矶山医院)麻醉手术室,安徽芜湖 241000

心脏手术 体外膜肺氧合 体外循环 转运

安徽省医疗卫生重点专科建设项目

2021-273

2024

中华危重病急救医学
中华医学会

中华危重病急救医学

CSTPCD北大核心
影响因子:3.049
ISSN:2095-4352
年,卷(期):2024.36(4)